US Stock MarketDetailed Quotes

MRVI Maravai LifeSciences

Watchlist
  • 2.915
  • -0.105-3.48%
Trading Mar 4 09:42 ET
413.47MMarket Cap-1.75P/E (TTM)

Maravai LifeSciences Key Stats

Maravai LifeSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 63.148M--
--2024/Q4-- / 57.785M--
Nov 7, 20242024/Q365.200M / 67.729M--
Aug 7, 20242024/Q273.400M / 71.627M--
May 8, 20242024/Q164.179M / 60.545M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 63.148M--
--2024/Q4-- / 57.785M--
Nov 7, 20242024/Q365.200M / 67.729M--
Aug 7, 20242024/Q273.400M / 71.627M--
May 8, 20242024/Q164.179M / 60.545M--

Unlock Free Earnings Estimates

Maravai LifeSciences Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 4, 2025

Buy

  • Buy

    57.14%
  • Hold

    28.57%
  • Sell

    14.29%

Price Target

No Data